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Recombinant tissue-type plasminogen activator
(rt-PA)
EEG
Back-average analysisWe describe a patient with an acute middle cerebral artery ischemic stroke developing subtle involuntary
movements of the paretic upper limb with cortical origin during rt-PA perfusion. Despite the multiple potential
pathophysiologicalmechanisms for the relationship between thrombolysis and epileptic activity, seizures during
this procedure are scarcely reported. Our hypothesis is that subtle and transient clinical seizures, like those
described in our patient, may not be detected or are misdiagnosed as nonepileptic involuntary movements.
We aimed to draw attention to the recognition challenge of this paroxysmal motor behavior, highlighting this
clinical and neurophysiological identiﬁcation using video recording and back-average analysis of the EEG.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Early poststroke seizures (i.e. occurring within one week after
stroke) are thought to result from cellular biochemical dysfunction
leading to electrically irritable cerebral tissue. Intravenous thrombolysis
(IVT)with recombinant tissue-type plasminogen activator (rt-PA) is the
gold standard treatment for acute ischemic stroke, and, recently, Alva-
rez et al., [1] showed that this procedure may be independently associ-
ated with early seizures. However, and despite multiple potential
pathophysiological mechanisms, seizures coincident with rt-PA admin-
istration are seldom reported. Here, we describe a patient with an acute
middle cerebral artery (MCA) ischemic strokewho developed subtle in-
voluntary movements of the paretic upper limb, with cortical origin as
documented neurophysiologically, during rt-PA perfusion. We aimed
to draw attention to the recognition challenge of this paroxysmal
motor behavior, highlighting its clinical and neurophysiological identiﬁ-
cation using video recording and back-average analysis of the EEG.2. Case report
A 72-year-old male with a past history of hypertension, dyslipid-
emia, chronic kidney disease, and an ischemic stroke 15 years ago,rviço deNeurologia, Hospital de
028 Lisboa, Portugal. Tel.:+351
m.ul.pt (C. Bentes).
. This is an open access article underwith no poststroke seizures and from which he had completely recov-
ered, presented to the emergency department with sudden onset of
left central facial palsy, hemiparesis, homonymous hemianopsia, and
right gaze deviation (NIHSS score = 10). Electrocardiogram showed
atrial ﬁbrillation, and blood analysis revealed acute renal failure (creati-
nine = 4 mg/dL, blood urea nitrogen = 134 mg/dL). Plain head com-
puted tomography (CT) disclosed old occipital, parietal, and frontal
ischemic lesions and a rightmiddle cerebral artery (MCA) hyperdensity.
Intravenous recombinant tissue-type plasminogen activator (rt-PA)was
started 140min after symptom onset. Twentyminutes after starting the
infusion period, involuntary movements of the upper paretic limb were
noticed. The movements involved either the distal or the proximal
muscles, independently, and could be jerk-like, irregular, myoclonic-
like, or slow and brief (Video). During rt-PA perfusion, a 72-channel
EEG (International 10/10 System) with an EMG channel recording the
leftﬂexor digitorumsuperﬁcialis (sample frequency of 1000Hz) captured
brief, repetitive, and almost periodic muscle activations (Fig. 1A). No
epileptiform activity was apparent in the raw EEG data. Back-average
analysis of the EEG time-lockedwith the onset of the recordedmyoclonus
(538 activations)was performed (BESA software, version 6.0), revealing a
right frontocentral negative wave. This EEG transient preceded muscle
activation by 30 ms (Fig. 1B). No antiepileptic drug was given, and the
involuntary movements lasted approximately 40 min, stopping by the
end of the rt-PA perfusion. The neurological deﬁcit did not improve
after thrombolysis. Transcranial Doppler showed no recanalization.
Computed tomography at 24 h disclosed an acute MCA infarct scoring
5 on ASPECTS, with spared cortical areas within the infarct zonethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1.A) EMG channel recording the leftﬂexor digitorum superﬁcialis capturing brief, repetitive, and almost periodicmuscle activations (arrows). B) EEG back-average analysis disclosing
a negative transient (arrows) with a peak (yellow line) of 10 ms before EMG activations (dotted line) at right central electrodes (C4/FC4).
187C. Bentes et al. / Epilepsy & Behavior Case Reports 2 (2014) 186–188(Fig. 2). The patient partially recovered after 7 days (NIHSS score = 6).
No further involuntary movements or clinically suspected seizures
were observed despite transitory worsening of renal function during
hospitalization. One year after stroke, the patient is alive and indepen-
dent (NIHSS = 1 and mRS = 1), with no report of late poststroke
seizures.
3. Discussion
We report a patient with an acute MCA ischemic stroke who devel-
oped subtle involuntary movements of the paretic upper limb, with
cortical origin as documented neurophysiologically, during rt-PA perfu-
sion. Because cortical myoclonus and epileptogenic discharges are
generated by neuronal hypersynchronous activities sharing the same
physiopathogenic mechanisms, the recordedmyoclonus can be consid-
ered an acute symptomatic seizure. Because of the subtleness of the
movements, the clinical stability of the patient, and the absence of
clear epileptiform activity on the immediate raw EEG analysis, noantiepilepticmedicationwas given. Back-average analysis, enlightening
the cortical origin of themyoclonus, was only performed after the acute
phase.
Even though our patient hadmultiple risk factors for seizures (acute
renal lesion, acute anterior stroke, cortical involvement), the close time
relationship of this paroxysmal motor behavior with the therapeutic
intervention raises the possibility of an association. It has been docu-
mented that seizures during rt-PA perfusion can occur even in the
absence of a cerebral lesion, as described in 2 patients submitted to
thrombolysis for acute myocardial infarction [2]. In fact, neurotoxic
and epileptogenic properties [3] of rt-PA are known. Other postulated
mechanisms for seizures during thrombolysis for ischemic stroke in-
clude secondary cortical infarct from distal embolization or reperfu-
sion/hyperperfusion syndrome [4].
Despite the multiple potential pathophysiological mechanisms for
the relationship between rt-PA and seizures, the frequency of seizures
during thrombolysis is not well known. Besides a few reports of overt
seizures occurring in close proximity to rt-PA perfusion [2,3], most
Fig. 2. Plain head CT scan 24 h after thrombolysis disclosing an acute rightMCA infarct, scoring 5 (I, M1, M2, M5, M6) on ASPECTS score, with spared cortical areas within the infarct zone.
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thrombolysis report a global incidence of seizures within 7 days after
stroke and not speciﬁcally during the therapeutic procedure. In these
studies, patients submitted to thrombolysis have similar frequency of
early seizures when compared with patients without thrombolysis.
Only one study concluded that thrombolysis is an independent risk fac-
tor for early seizures after stroke [1]. These discrepanciesmay be related
to the retrospective collection of the data. Additionally, reporting bias
due to increased clinical vigilance in the acute phase of patients under-
going thrombolysis cannot be excluded. Finally, it is also possible that
subtle and transient clinical seizures, like those described in our patient,
may not be detected or are misdiagnosed as nonepileptic involuntary
movements.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebcr.2014.09.004.
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